MOH
- Marketing authorisation holder: X4 PHARMS
- Status: likely_approved
🇮🇱 Xolremdi in Israel
Xolremdi (MAVORIXAFOR) regulatory status in Israel.
Marketing authorisation
Xolremdi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Israel
Frequently asked questions
Is Xolremdi approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Xolremdi in Israel?
X4 PHARMS holds the Israeli marketing authorisation.